Application 209235
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE | CAPSULE;ORAL | EQ 200MG FREE ACID AND POTASSIUM SALT;30MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209235-001 | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE | EQ 200MG FREE ACID AND POTASSIUM SALT;30MG | CAPSULE / ORAL | 2017-12-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209235-001 | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | EQ 200MG FREE ACID AND POTASSIUM SALT;30MG | CAPSULE / ORAL | 2017-12-01 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A209235-001 | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | EQ 200MG FREE ACID AND POTASSIUM SALT;30MG | CAPSULE / ORAL | 2017-12-01 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A209235-001 | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | EQ 200MG FREE ACID AND POTASSIUM SALT;30MG | CAPSULE / ORAL | 2017-12-01 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A209235-001 | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | EQ 200MG FREE ACID AND POTASSIUM SALT;30MG | CAPSULE / ORAL | 2017-12-01 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A209235-001 | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | EQ 200MG FREE ACID AND POTASSIUM SALT;30MG | CAPSULE / ORAL | 2017-12-01 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen and Pseudoephedrine HCl | IBUPROFEN AND PSEUDOEPHEDRINE HCL | WALGREEN CO. | 1cc6e3f0-64f7-4974-a62c-5db46ca9e7c5 | 2023-09-08 | Warnings | 209235 ANDA209235 0363-1106 |
| Ibuprofen and Pseudoephedrine HCl | IBUPROFEN AND PSEUDOEPHEDRINE HCL | CVS Pharmacy, Inc. | b8a4d9be-e202-4f99-bece-e2125aaca8b9 | 2023-07-14 | Warnings | 209235 ANDA209235 69842-092 |
| Ibuprofen and Pseudoephedrine HCl | IBUPROFEN AND PSEUDOEPHEDRINE HCL | Amerisource Bergen | 8d397f4f-ac5e-426d-a26b-ee064b6e5028 | 2022-11-04 | Warnings | 209235 ANDA209235 46122-609 |
| Ibuprofen and Pseudoephedrine HCl | IBUPROFEN AND PSEUDOEPHEDRINE HCL | Aurohealth LLC | 6adf9292-b4af-4cb4-99f3-dda03734570a | 2022-01-21 | Warnings | 209235 ANDA209235 58602-803 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0363-1106 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | WALGREEN CO. | ANDA | Current |
| 0363-1106 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | WALGREEN CO. | ANDA | Current |
| 0363-1106 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | WALGREEN CO. | ANDA | Current |
| 46122-609 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | Amerisource Bergen | ANDA | Current |
| 46122-609 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | Amerisource Bergen | ANDA | Current |
| 46122-609 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | Amerisource Bergen | ANDA | Current |
| 58602-803 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | Aurohealth LLC | ANDA | Current |
| 58602-803 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | Aurohealth LLC | ANDA | Current |
| 58602-803 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | Aurohealth LLC | ANDA | Current |
| 58602-803 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | Aurohealth LLC | ANDA | Current |
| 58602-803 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | Aurohealth LLC | ANDA | Current |
| 69842-092 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | CVS Pharmacy, Inc. | ANDA | Current |
| 69842-092 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | CVS Pharmacy, Inc. | ANDA | Current |
| 69842-092 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | CVS Pharmacy, Inc. | ANDA | Current |
| 70000-0606 | Ibuprofen and Pseudoephedrine HCl | Ibuprofen and Pseudoephedrine HCl | Cardinal Health | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 50986 | ORIG | 2018-01-08 |